Premium
Antimalarials
Author(s) -
Van Beek Marta J.,
Piette Warren W.
Publication year - 2001
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1046/j.1529-8019.2001.014002143.x
Subject(s) - medicine , immune system , immunology , concomitant , drug , lupus erythematosus , immune modulation , systemic lupus erythematosus , disease , dermatology , intensive care medicine , pharmacology , surgery , antibody
Over the last century, antimalarial medications have become the parenteral drugs of choice for treating the cutaneous manifestations of lupus erythematosus. The effects of immune modulation with the concomitant preservation of host immune response to exogenous antigens procures these agents as powerful tools in a wide range of conditions. With prudent dosage and monitoring, antimalarials can be used safely and effectively in the treatment and management of autoimmune connective tissue disease.